Hims & Hers Health, Inc.HIMS
NYSE•Healthcare•Drug Manufacturers - Specialty & Generic
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $2.37B, growing 32.8% year-over-year. TTM net income stood at $-13.23M (108.1% contraction). Quarterly EBITDA was $-56.37M and operating income was $-78.32M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze HIMS growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters